362 related articles for article (PubMed ID: 25999226)
1. Posttreatment Lyme disease syndrome.
Aucott JN
Infect Dis Clin North Am; 2015 Jun; 29(2):309-23. PubMed ID: 25999226
[TBL] [Abstract][Full Text] [Related]
2. Update of the Swiss guidelines on post-treatment Lyme disease syndrome.
Nemeth J; Bernasconi E; Heininger U; Abbas M; Nadal D; Strahm C; Erb S; Zimmerli S; Furrer H; Delaloye J; Kuntzer T; Altpeter E; Sturzenegger M; Weber R; For The Swiss Society For Infectious Diseases And The Swiss Society For Neurology
Swiss Med Wkly; 2016; 146():w14353. PubMed ID: 27922168
[TBL] [Abstract][Full Text] [Related]
3. The challenge of Lyme disease: tired of the Lyme wars.
Kullberg BJ; Berende A; van der Meer JW
Neth J Med; 2011 Mar; 69(3):98-100. PubMed ID: 21444933
[No Abstract] [Full Text] [Related]
4. Common misconceptions about Lyme disease.
Halperin JJ; Baker P; Wormser GP
Am J Med; 2013 Mar; 126(3):264.e1-7. PubMed ID: 23321431
[TBL] [Abstract][Full Text] [Related]
5. Persistent Symptoms After Treatment of Lyme Disease.
Marques A
Infect Dis Clin North Am; 2022 Sep; 36(3):621-638. PubMed ID: 36116839
[TBL] [Abstract][Full Text] [Related]
6. Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?
Aucott JN; Rebman AW; Crowder LA; Kortte KB
Qual Life Res; 2013 Feb; 22(1):75-84. PubMed ID: 22294245
[TBL] [Abstract][Full Text] [Related]
7. [Post Lyme syndrome as a clinical problem].
Moniuszko A; Czupryna P; Zajkowska J; Pancewicz SA; Grygorczuk S; Kondrusik M
Pol Merkur Lekarski; 2009 Mar; 26(153):227-30. PubMed ID: 19388538
[TBL] [Abstract][Full Text] [Related]
8. A Distinct Microbiome Signature in Posttreatment Lyme Disease Patients.
Morrissette M; Pitt N; González A; Strandwitz P; Caboni M; Rebman AW; Knight R; D'Onofrio A; Aucott JN; Soloski MJ; Lewis K
mBio; 2020 Sep; 11(5):. PubMed ID: 32994327
[TBL] [Abstract][Full Text] [Related]
9. Sleep quality in well-defined Lyme disease: a clinical cohort study in Maryland.
Weinstein ER; Rebman AW; Aucott JN; Johnson-Greene D; Bechtold KT
Sleep; 2018 May; 41(5):. PubMed ID: 29452400
[TBL] [Abstract][Full Text] [Related]
10. Non-specific symptoms and post-treatment Lyme disease syndrome in patients with Lyme borreliosis: a prospective cohort study in Belgium (2016-2020).
Geebelen L; Lernout T; Devleesschauwer B; Kabamba-Mukadi B; Saegeman V; Belkhir L; De Munter P; Dubois B; Westhovens R; ; Van Oyen H; Speybroeck N; Tersago K
BMC Infect Dis; 2022 Sep; 22(1):756. PubMed ID: 36171561
[TBL] [Abstract][Full Text] [Related]
11. [Articular symptoms in Lyme borreliosis].
Grygorczuk S; Pancewicz S; Zajkowska J; Kondrusik M; Moniuszko A
Pol Merkur Lekarski; 2008 Jun; 24(144):542-4. PubMed ID: 18702339
[TBL] [Abstract][Full Text] [Related]
12. Musculoskeletal manifestations of Lyme disease.
Bitar I; Lally EV
Med Health R I; 2008 Jul; 91(7):213-5. PubMed ID: 18705221
[TBL] [Abstract][Full Text] [Related]
13. Lyme disease associated with fibromyalgia.
Dinerman H; Steere AC
Ann Intern Med; 1992 Aug; 117(4):281-5. PubMed ID: 1637022
[TBL] [Abstract][Full Text] [Related]
14. Posttreatment Lyme Disease Syndrome-What It Might Be and What It Is Not.
Schmid H; Heininger U
Pediatr Infect Dis J; 2021 May; 40(5S):S31-S34. PubMed ID: 34042908
[TBL] [Abstract][Full Text] [Related]
15. A Review of Post-treatment Lyme Disease Syndrome and Chronic Lyme Disease for the Practicing Immunologist.
Wong KH; Shapiro ED; Soffer GK
Clin Rev Allergy Immunol; 2022 Feb; 62(1):264-271. PubMed ID: 34687445
[TBL] [Abstract][Full Text] [Related]
16. CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.
Aucott JN; Soloski MJ; Rebman AW; Crowder LA; Lahey LJ; Wagner CA; Robinson WH; Bechtold KT
Clin Vaccine Immunol; 2016 Sep; 23(9):757-66. PubMed ID: 27358211
[TBL] [Abstract][Full Text] [Related]
17. Systematic comparisons between Lyme disease and post-treatment Lyme disease syndrome in the U.S. with administrative claims data.
Chung MK; Caboni M; Strandwitz P; D'Onofrio A; Lewis K; Patel CJ
EBioMedicine; 2023 Apr; 90():104524. PubMed ID: 36958992
[TBL] [Abstract][Full Text] [Related]
18. The Clinical, Symptom, and Quality-of-Life Characterization of a Well-Defined Group of Patients with Posttreatment Lyme Disease Syndrome.
Rebman AW; Bechtold KT; Yang T; Mihm EA; Soloski MJ; Novak CB; Aucott JN
Front Med (Lausanne); 2017; 4():224. PubMed ID: 29312942
[TBL] [Abstract][Full Text] [Related]
19. Development of a foundation for a case definition of post-treatment Lyme disease syndrome.
Aucott JN; Crowder LA; Kortte KB
Int J Infect Dis; 2013 Jun; 17(6):e443-9. PubMed ID: 23462300
[TBL] [Abstract][Full Text] [Related]
20. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial.
Krupp LB; Hyman LG; Grimson R; Coyle PK; Melville P; Ahnn S; Dattwyler R; Chandler B
Neurology; 2003 Jun; 60(12):1923-30. PubMed ID: 12821734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
